Volpara (ASX:VHT) share price pushes higher on FY 2021 results

The Volpara Health Technologies Ltd (ASX:VHT) share price is on the move on Thursday following the release of its full year results…

| More on:
A doctor looks unsure, indicating share price uncertainty for ASX medical companies

Image source: Getty images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Volpara Health Technologies Ltd (ASX: VHT) share price is pushing higher on Thursday.

At the time of writing, the healthcare technology company's shares are up 1% to $1.26.

Why is the Volpara share price pushing higher?

Investors have been buying the company's shares following the release of its full year results for FY 2021.

For the 12 months ending 31 March, Volpara reported record revenue from customer contracts of NZ$19.7 million. This was a 57% increase on the prior corresponding period and driven by a 99% lift in subscription revenue to NZ$18.1 million.

This was driven by further market share gains. Approximately 32% of US women now have a Volpara product applied on their images and data. This compares to 27% at the end of the prior corresponding period.

Another positive was the company's gross margin, which expanded from 86% to 91%. This was driven by several factors, including a focus on cost reductions and scalability of Microsoft Azure, which is its largest cost-of-revenue expense item. Management expects its gross margins to remain within 90% to 92% in FY 2022.

The company's operating costs increased by just 8% during the year to NZ$39 million. Management advised that costs would have been flat excluding the first full year of MRS costs and two months of CRA costs.

This ultimately led to the company reporting a 14% improvement in its net loss to NZ$17.5 million for the year. Pleasingly, Volpara has the balance sheet strength to withstand this loss. At the end of the period, the company's cash balance stood at NZ$32.2 million.

Management commentary

Volpara's CEO and Chief Scientist, Dr Ralph Highnam, said: "FY2021 was an excellent year for Volpara. We successfully conducted our second acquisition, of Boston-based breast cancer risk company CRA Health, LLC, but we've also done a huge amount of work behind the scenes to make the company more scalable: digital marketing through to smarter use of our cloud services through to easier-to-deploy software systems into clinics."

"It's great to see that work start to come through in the numbers as we see Gross Margin moving upwards and the net loss coming down, even as we continue to grow at a strong pace. We look forward with relish to now Accelerating Out of COVID-19 and reporting on those results during FY2022," he added.

Outlook

Management expects its growth to continue in FY 2022. It has provided revenue guidance of approximately NZ$25 million to NZ$26 million. This represents year on year growth of 27% to 32%.

And, as mentioned above, the company is expecting its gross margins to be in the range of 90% to 92% in FY 2022.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends VOLPARA FPO NZ. The Motley Fool Australia has recommended VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Flight Centre, Monash IVF, NextDC, and Woodside shares are sinking today

These shares are having a tough finish to the week. Let's see what is going on.

Read more »

A woman in a business suit holds a large gold bar in both hands with a gold arrow tracking upwards.
Gold

Gold price hits new all-time-high above US$3,200. Can it keep going?

Demand for precious metals could go higher from here.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Market News

Are you buying the dip? Here are the top 10 ASX shares Aussie investors are targeting

Data from trading platform Stake reveals the most popular ASX shares among investors buying the dip.

Read more »

seismograph with dollar sign
Share Market News

After hitting a five-year low, does the Australian dollar have further to fall as the trade war plays out?

The Australian dollar has been hit on multiple fronts. Where is it heading from here?

Read more »

Three miners stand together at a mine site studying documents with equipment in the background
Resources Shares

What does Macquarie think Fortescue shares are worth?

Is the iron ore giant about to turn a corner?

Read more »

Person holding Australian dollar notes, symbolising dividends.
Share Market News

5 ASX dividend shares to buy and hold for the next 20 years

Analysts think these shares could be great long term picks for income investors.

Read more »

A young couple sits at their kitchen table looking at documents with a laptop open in front of them while they consider the state of their investments.
Broker Notes

AGL shares: a potential beneficiary of the Federal Government's proposed household battery subsidy?

Is this plan going to recharge investor excitement about AGL?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Share Market News

5 things to watch on the ASX 200 on Friday

The share market recovery looks set to run out of steam today.

Read more »